Association of salivary Interleukin-6 levels in smokers with periodontitis
Main Article Content
Abstract
Background: Periodontal disease is caused by a combination of factors, with a plaque being the primary causative factor. Although periodontal bacteria play a significant contribution in the onset of periodontitis, the sustained inflammatory immune reaction, which is mostly directed by the elevation of pro-inflammatory cytokines, is the primary component responsible for tissue damage associated with periodontitis. Interleukin (IL)-6 is a pleiotropic cytokine, and it is released by a variety of cell types. IL-6 is crucial in the processes that lead to periodontal disease and has also been linked to the migration of inflammatory cells. Smoking is a key potential factor for periodontal disorders and is associated with an increase in both the onset and severity of periodontitis, this studay aims to assess the association between smoking cigarettes and the salivary levels of IL-6 in patients with periodontitis in comparison to healthy controls. Materials and Methods: The sample population consisted of seventy-four males, and they were separated into four different groups: a clinically healthy periodontium non-smoker group (n=12), a clinically healthy periodontium smoker group (n=12), a periodontitis non-smoker group (n=25) and a periodontitis smoker group (n=25). All of the participants' saliva samples were taken, and then clinical periodontal parameters were looked at (plaque index, bleeding on probing, probing pocket depth and clinical attachment level). Biochemical analysis with an Enzyme-Linked Immunosorbent Assay (ELISA) was used to find out how much IL-6 was in the saliva. Results: The levels of IL-6 were found to be greater in the periodontitis groups compared to the control groups and in the smoking groups compared to the non-smoking groups. Most periodontal measures correlated significantly with IL-6 concentration in the saliva.Conclusion: This research revealed that smokers (both with and without periodontitis) have higher amounts of IL-6 in their saliva than nonsmokers (both healthy and periodontitis). This shows that smoking cigarettes had a boosting effect on the levels of IL-6 in the saliva.
Received date: 01-02-2023
Accepted date: 06-04-2023
Published date: 15-12-2024
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
Publication Dates
References
Mohammed A, Fadhil R, Mahmood MS, Al-Waeli HA. Diagnostic biomarkers for periodontitis (observational case-control study). J Bagh Coll Dent. 2024;36(2):11-9. DOI: https://doi.org/10.26477/jbcd.v36i2.3673
Imran NK, Abdulbaqi HR, Milward M. The prevalence of periodontitis in an Iraqi population using the 2017 classification. J Bagh Coll Dent. 2024;36(2):1-0. DOI: https://doi.org/10.26477/jbcd.v36i2.3668
Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481-90. DOI: https://doi.org/10.1038/nrmicro2337
Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease. Int J Mol Sci. 2019;20(6):1414. DOI: https://doi.org/10.3390/ijms20061414
D'Aiuto F, Gable D, Syed Z, Allen Y, Wanyonyi KL, White S, et al. Evidence summary: The relationship between oral dis-eases and diabetes. Br Dent J. 2017;222(12):944-8. DOI: https://doi.org/10.1038/sj.bdj.2017.544
Alexandridi F, Tsantila S, Pepelassi E. Smoking cessation and response to periodontal treatment. Aust Dent J. 2018;63(2):140-9. DOI: https://doi.org/10.1111/adj.12568
Kanmaz M, Kanmaz B, Buduneli N. Periodontal treatment outcomes in smokers: A narrative review. Tob Induc Dis. 2021;19. DOI: https://doi.org/10.18332/tid/142106
Liu KH, Hwang SJ. Effect of smoking cessation for 1 year on periodontal biomarkers in gingival crevicular fluid. J Perio-dontal Res. 2016;51(3):366-75. DOI: https://doi.org/10.1111/jre.12316
Ribeiro FV, Pino DS, Franck FC, Benatti BB, Tenenbaum H, Davies JE, et al. Resveratrol inhibits periodontitis‐related bone loss in rats subjected to cigarette smoke inhalation. J Periodontol. 2017;88(8):788-98. DOI: https://doi.org/10.1902/jop.2017.170025
Lima FR, Cesar-Neto JB, Lima DR, Kerbauy WD, Nogueira-Filho GR. Smoking enhances bone loss in anterior teeth in a Brazilian population: a retrospective cross-sectional study. Braz Oral Res. 2008;22:328-33. DOI: https://doi.org/10.1590/S1806-83242008000400008
Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol. 1989 Oct;17(5):245-7 DOI: https://doi.org/10.1111/j.1600-0528.1989.tb00626.x
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleu-kin-6. Biochim Biophys Acta, Mol Cell Res. 2011;1813(5):878-88. DOI: https://doi.org/10.1016/j.bbamcr.2011.01.034
Garbers C, Heink S, Korn T, Rose-John S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat Rev Drug Discov. 2018;17(6):395-412. DOI: https://doi.org/10.1038/nrd.2018.45
khudhair Hussein D, Al-Jowari SA, Rahmah AM. Determination of the level of IL-6 and Vaspin in hyperthyroid patients treated with Carbimazole. Iraqi J Sci. 2022: 1909-17. DOI: https://doi.org/10.24996/ijs.2022.63.5.5
de Lima CL, Acevedo AC, Grisi DC, Taba Jr M, Guerra E, De Luca Canto G. Host‐derived salivary biomarkers in diag-nosing periodontal disease: Systematic review and meta‐analysis. J Clin Periodontol. 2016;43(6):492-502. DOI: https://doi.org/10.1111/jcpe.12538
Graziani F, Cei S, Orlandi M, Gennai S, Gabriele M, Filice N, et al. Acute‐phase response following full‐mouth versus quadrant non‐surgical periodontal treatment: A randomized clinical trial. J Clin Periodontol. 2015 Sep;42(9):843-52. DOI: https://doi.org/10.1111/jcpe.12451
Batool H, Nadeem A, Kashif M, Shahzad F, Tahir R, Afzal N. Salivary levels of IL-6 and IL-17 could be an indicator of disease severity in patients with calculus associated chronic periodontitis. Biomed Res Int. 2018;2018. DOI: https://doi.org/10.1155/2018/8531961
Wang F, Guan M, Wei L, Yan H. IL‑18 promotes the secretion of matrix metalloproteinases in human periodontal ligament fibroblasts by activating NF‑κB signaling. Mol Med Rep. 2019;19(1):703-10. DOI: https://doi.org/10.3892/mmr.2018.9697
Raheema DA, Kassab HJ. Preparation and in-vitro evaluation of secnidazole as periodontalin-situ gel for treatment of periodontal disease. Secnidazole dental in situ gel. Iraqi J Pharm Sci. 2022; 31(2):50-61. DOI: https://doi.org/10.31351/vol31iss2pp50-61
Madi M, Pavlic V, Samy W, Alagl A. The anti-inflammatory effect of locally delivered nano-doxycycline gel in therapy of chronic periodontitis. Acta Odontol Scand. 2018;76(1):71-6. DOI: https://doi.org/10.1080/00016357.2017.1385096
Bjartveit K, Tverdal A. Health consequences of smoking 1–4 cigarettes per day. Tob Control. 2005;14(5):315-20. DOI: https://doi.org/10.1136/tc.2005.011932
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classi-fication and case definition. J Periodontol. 2018;89:S159-72. DOI: https://doi.org/10.1002/JPER.18-0006
O’Leary T, Drake R. Naylor. Plaque control record. 1972. J Periodontol. 1972; 43(1): 38-38 DOI: https://doi.org/10.1902/jop.1972.43.1.38
Grönblad EA. Concentration of immunoglobulins in human whole saliva: effect of physiological stimulation. Acta Odontol Scand. 1982;40(2):87-95. DOI: https://doi.org/10.3109/00016358209041120
Naderi NJ, Semyari H, Elahinia Z. The impact of smoking on gingiva: a histopathological study. Iran J Pathol. 2015;10(3):214.
Gupta N, Gupta ND, Goyal L, Moin S, Khan S, Gupta A, et al. The influence of smoking on the levels of matrix metallo-proteinase-8 and periodontal parameters in smoker and nonsmoker patients with chronic periodontitis: A clinicobio-chemical study. J Oral Biol Craniofac Res. 2016;6:S39-43. DOI: https://doi.org/10.1016/j.jobcr.2015.08.004
Visvanathan R, Mahendra J, Ambalavanan N. Effect of smoking on periodontal health. J Clin Diagn Res. 2014;8(7):ZC46. DOI: https://doi.org/10.7860/JCDR/2014/8359.4597
Arowojolu MO, Fawole OI, Dosumu EB, Opeodu OI. A comparative study of the oral hygiene status of smokers and non-smokers in Ibadan, Oyo state. Niger Med J. 2013;54(4):240. DOI: https://doi.org/10.4103/0300-1652.119627
Jassim SD, Ibrahim LM. Correlation between Periodontal Health Status and Salivary Matrix Metalloproteinase-9 Levels in Smoker and Non-Smoker Chronic Periodontitis Patients (A Comparative Study). J Bagh Coll Dent. 2016;28(4):128-33. DOI: https://doi.org/10.12816/0033223
Chang CH, Han ML, Teng NC, Lee CY, Huang WT, Lin CT, et al. Cigarette smoking aggravates the activity of periodontal disease by disrupting redox homeostasis-an observational study. Sci Rep. 2018;8(1):1-0. DOI: https://doi.org/10.1038/s41598-018-29163-6
Kubota M, Tanno-Nakanishi M, Yamada S, Okuda K, Ishihara K. Effect of smoking on subgingival microflora of patients with periodontitis in Japan. BMC oral health. 2011;11(1):1-6. DOI: https://doi.org/10.1186/1472-6831-11-1
Kanmaz B, Lamont G, Danacı G, Gogeneni H, Buduneli N, Scott DA. Microbiological and biochemical findings in relation to clinical periodontal status in active smokers, non-smokers and passive smokers. Tob Induc Dis. 2019;17. DOI: https://doi.org/10.18332/tid/104492
Buduneli N, Scott DA. Tobacco‐induced suppression of the vascular response to dental plaque. Mol Oral Microbiol. 2018;33(4):271-82. DOI: https://doi.org/10.1111/omi.12228
Ameer LR, Ali BG. Effects of light smoking on salivary levels of alkaline phosphatase and osteocalcin in chronic perio-dontitis patients. J Bagh Coll Dent. 2015;27(2):110-4. DOI: https://doi.org/10.12816/0015305
Shereef M, Sanara PP, Karuppanan S, Noorudeen AM, Joseph K. The effect of cigarette smoking on the severity of perio-dontal diseases among adults of Kothamangalam Town, Kerala. J Pharm Bioallied Sci. 2015;7(Suppl 2):S648. DOI: https://doi.org/10.4103/0975-7406.163588
Mokeem SA, Alasqah MN, Michelogiannakis D, Al-Kheraif AA, Romanos GE, Javed F. Clinical and radiographic perio-dontal status and whole salivary cotinine, IL-1β and IL-6 levels in cigarette-and waterpipe-smokers and E-cig users. Envir Toxicol Pharmacol. 2018;61:38-43. DOI: https://doi.org/10.1016/j.etap.2018.05.016
Katz J, Caudle RM, Bhattacharyya I, Stewart CM, Cohen DM. Receptor for advanced glycation end product (RAGE) up-regulation in human gingival fibroblasts incubated with nornicotine. J Peridontol. 2005;76(7):1171-4. DOI: https://doi.org/10.1902/jop.2005.76.7.1171
Haseeb M, Khawaja KI, Ataullah K, Munir MB, Fatima A. Periodontal disease in type 2 diabetes mellitus. J Coll Physicians Surg Pak. 2012;22(8):514-8.
Javed F, Abduljabbar T, Vohra F, Malmstrom H, Rahman I, Romanos GE. Comparison of periodontal parameters and self‐perceived oral symptoms among cigarette smokers, individuals vaping electronic cigarettes, and never‐smokers. J Perio-dontol. 2017;88(10):1059-65. DOI: https://doi.org/10.1902/jop.2017.170197
Nima RS, Aziz DZ. The Oxidative Stress Induced by the Vapours of Electronic-Hookah on Mice Liver Tissues. Sys Rev Pharm. 2020;11(9):420-3.
Ebersole JL, Schuster JL, Stevens J, Dawson D, Kryscio RJ, Lin Y, et al. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol. 2013;33(1):271-9. DOI: https://doi.org/10.1007/s10875-012-9771-3
Kusuyama J, Nakamura T, Ohnishi T, Albertson BG, Ebe Y, Eiraku N, et al. Low‐intensity pulsed ultrasound promotes bone morphogenic protein 9‐induced osteogenesis and suppresses inhibitory effects of inflammatory cytokines on cellular responses via Rho‐associated kinase 1 in human periodontal ligament fibroblasts. J Cell Biochem. 2019;120(9):14657-69. DOI: https://doi.org/10.1002/jcb.28727
Isola G, Giudice AL, Polizzi A, Alibrandi A, Murabito P, Indelicato F. Identification of the different salivary Interleukin-6 profiles in patients with periodontitis: a cross-sectional study. Arch Oral Biol. 2021;122:104997. DOI: https://doi.org/10.1016/j.archoralbio.2020.104997
Sharma M, Bairy I, Pai K, Satyamoorthy K, Prasad S, Berkovitz B, et al. Salivary IL-6 levels in oral leukoplakia with dys-plasia and its clinical relevance to tobacco habits and periodontitis. Clinic Oral Investig. 2011;15(5):705-14. DOI: https://doi.org/10.1007/s00784-010-0435-5
Javed F, Al‐Kheraif AA, Al Amri MD, Alshehri M, Vohra F, Al‐Askar M, et al. Periodontal status and whole salivary cy-tokine profile among smokers and never‐smokers with and without prediabetes. J Periodontol. 2015;86(7):890-8. DOI: https://doi.org/10.1902/jop.2015.140593
Suzuki N, Nakanishi K, Yoneda M, Hirofuji T, Hanioka T. Relationship between salivary stress biomarker levels and cig-arette smoking in healthy young adults: an exploratory analysis. Tob Induc Dis. 2016;14(1):1-7. DOI: https://doi.org/10.1186/s12971-016-0085-8
Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, et al. Identification of pathogen and host response markers correlated with periodontal disease. J Periodontol. 2009;80(3):436-46. DOI: https://doi.org/10.1902/jop.2009.080480
Gursoy UK, Könönen E, Uitto VJ, Pussinen PJ, Hyvärinen K, Suominen‐Taipale L, et al. Salivary interleukin‐1β concen-tration and the presence of multiple pathogens in periodontitis. J Clin Periodontol. 2009;36(11):922-7. DOI: https://doi.org/10.1111/j.1600-051X.2009.01480.x
Teles RP, Likhari V, Socransky SS, Haffajee AD. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross‐sectional study. J Periodontal Res. 2009;44(3):411-7. DOI: https://doi.org/10.1111/j.1600-0765.2008.01119.x
Kibayashi M, Tanaka M, Nishida N, Kuboniwa M, Kataoka K, Nagata H, et al. Longitudinal study of the association between smoking as a periodontitis risk and salivary biomarkers related to periodontitis. J Periodontol. 2007;78(5):859-67. DOI: https://doi.org/10.1902/jop.2007.060292
Rathnayake N, Åkerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, et al. Salivary biomarkers for detection of systemic diseases. PloS One. 2013;8(4):e61356. DOI: https://doi.org/10.1371/journal.pone.0061356
Morozumi T, Yashima A, Gomi K, Ujiie Y, Izumi Y, Akizuki T, et al. Increased systemic levels of inflammatory mediators following one‐stage full‐mouth scaling and root planing. J Periodontal Res. 2018;53(4):536-44. DOI: https://doi.org/10.1111/jre.12543
Beklen AR, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of Toll‐like receptors 1–10 in periodontitis. Oral Microbial Immunol. 2008;23(5):425-31. DOI: https://doi.org/10.1111/j.1399-302X.2008.00448.x
Carranza F, Henry H, Newman M. G Clinical periodontology 12th edition.
Javed F, Altamash M, Klinge B, Engström PE. Periodontal conditions and oral symptoms in gutka-chewers with and without type 2 diabetes. Acta Odontol Scand. 2008;66(5):268-73. DOI: https://doi.org/10.1080/00016350802286725
Javed F, Samaranayake LP, Al-Askar M, Al-Hezaimi K. Periodontal disease in habitual cigarette smokers and nonsmokers with and without prediabetes. Am J Med Sci. 2013;345(2):94-8. DOI: https://doi.org/10.1097/MAJ.0b013e31824d5337
Wendell KJ, Stein SH. Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. J Periodontol. 2001;72(8):1038-44. DOI: https://doi.org/10.1902/jop.2001.72.8.1038
Javed F, Ahmed HB, Saeed A, Mehmood A, Bain C. Whole salivary interleukin‐6 and matrix metalloproteinase‐8 levels in patients with chronic periodontitis with and without prediabetes. J Periodontol. 2014;85(5):e130-5. DOI: https://doi.org/10.1902/jop.2013.130514
Hadzic Z, Pasic E, Hukic M, Vukelic MG, Hadzic S. Salivary Interleukin-6 Levels in Patients with Periodontitis Stage IV. Meandros Med Dental J. 2021;22(2):140. DOI: https://doi.org/10.4274/meandros.galenos.2021.05945
Reis C, Da Costa AV, Guimarães JT, Tuna D, Braga AC, Pacheco JJ, et al. Clinical improvement following therapy for periodontitis: Association with a decrease in IL‑1 and IL‑6. Exp Ther Med . 2014;8(1):323-7. DOI: https://doi.org/10.3892/etm.2014.1724
Keles Yucel ZP, Keles GC, Avci B, Cetinkaya BO. Nonsurgical Periodontal Therapy Reduces Salivary and Gingival Crevicular Fluid YKL-40 and IL-6 Levels in Chronic Periodontitis. Oral Health Prev Dent. 2020;18(4):815-822.